VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $368,662,000 | -26.2% | 2,075,000 | -7.8% | 1.02% | -23.0% |
| Q2 2015 | $499,372,000 | +57.2% | 2,250,123 | +40.0% | 1.32% | +49.1% |
| Q1 2015 | $317,583,000 | -47.4% | 1,607,523 | -61.8% | 0.88% | -44.7% |
| Q4 2014 | $603,975,000 | +0.7% | 4,205,823 | -7.9% | 1.60% | -1.7% |
| Q3 2014 | $599,544,000 | +9.2% | 4,565,723 | +5.3% | 1.63% | +7.8% |
| Q2 2014 | $549,049,000 | +1.0% | 4,333,923 | +5.1% | 1.51% | -7.8% |
| Q1 2014 | $543,550,000 | +14.1% | 4,125,023 | +1.6% | 1.64% | +13.1% |
| Q4 2013 | $476,249,000 | +11.8% | 4,060,457 | -0.4% | 1.44% | +19.3% |
| Q3 2013 | $426,043,000 | +17.7% | 4,077,557 | -3.2% | 1.21% | +15.6% |
| Q2 2013 | $361,977,000 | – | 4,211,157 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |